Hot Stocks Of The Day (CPRX, ARUN, DSCO, ONTY, HMSY)

Discovery Laboratories, Inc. (NASDAQ:DSCO) shares climbed 7.97% to $2.71 after Analysts at Stifel Nicolaus initiated coverage on shares of Discovery Laboratori (NASDAQ: DSCO) in a research report issued to clients and investors today and the firm set a “buy” rating and a $5.00 price target on the stock.

Can DSCO Extend Gains? If yes, how far it can go? Find Out Here

Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) stock gained 6.98% to $1.84. The company reported a second quarter net loss of $289,080, or $0.01 per basic and diluted share, as compared to a net loss of $1,394,151, or $0.06 per basic and diluted share, for the same period in 2011. As a development-stage specialty pharmaceutical company, Catalyst had no revenues in either the second quarter of 2012 or first six months of 2012.

Aruba Networks, Inc. (NASDAQ:ARUN) shares climbed 17.55% to $19.89 in the early hour after the company posted fourth-quarter loss of $3.0 million or $0.03 per share, as compared to profit of $68.2 million or $0.57 per share in the same quarter last year. Adjusted earnings improved to $0.18 per share from $0.17 per share in the same period last year. Revenues for the quarter grew to $139.2 million from $113.8 million in the year ago period. Analysts expected earnings of $0.17 per share on revenues of $136.82 million for the quarter.

How Should Investors Trade ARUN Now? Find Out Here

Oncothyreon Inc (USA) (NASDAQ:ONTY) shares jumped 10.30% to $4.82 after Equities researchers at Stifel Nicolaus assumed coverage on shares of Oncothyreon in a report issued today. The firm set a “buy” rating and a $10.00 price target on the stock. On average, analysts predict that Oncothyreon Inc . will post $0.00 earnings per share for the current fiscal year.

HMS Holdings Corp. (NASDAQ:HMSY) stock plunged 8.30% to $32.33. HMS, a wholly owned subsidiary of HMS Holdings Corp. announced that it has been awarded a contract by the Commonwealth of Virginia, Department of Medical Assistance Services (DMAS), to serve as the Commonwealth’s Medicaid Recovery Audit Contractor (RAC). Under the terms of this contract, HMS will audit both in-state and out-of-state providers participating in the Virginia Medicaid program to identify underpayments and overpayments for all claims paid under the Medicaid and CHIP programs. The contract has an initial term of three years and includes three one-year renewal options.